Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer
Abstract The purpose of this study was to compare the changes in DXA values including trabecular bone score (TBS) and bone mineral density (BMD) of lumbar spine (LS) and femur according to the hormone therapies including tamoxifen (TMXF) treatment with or without gonadotropin releasing hormone analo...
Guardado en:
Autores principales: | Eun Heui Kim, Yun Kyung Jeon, Kyoungjune Pak, Taewoo Kang, Kyung-Eun Kim, Seong-Jang Kim, In-Joo Kim, Keunyoung Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f438a0fdd9a4a17891e7ff7ff2ac674 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endocrine and molecular milieus of ovarian follicles are diversely affected by human chorionic gonadotropin and gonadotropin-releasing hormone in prepubertal and mature gilts
por: Adam J. Ziecik, et al.
Publicado: (2021) -
Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero
por: RECABARREN,SERGIO E, et al.
Publicado: (2005) -
Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer.
por: Shiu-Dong Chung, et al.
Publicado: (2014) -
Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Muzi Li, et al.
Publicado: (2021) -
Association between thyroid hormones and insulin resistance indices based on the Korean National Health and Nutrition Examination Survey
por: Yun Mi Choi, et al.
Publicado: (2021)